MIRA
LIVE

Serial Number

98882583

Owner

Quanovate Tech Inc.

Attorney

Cher Sauer

First Use Date

Dec 13, 2018

Filing Date

Dec 3, 2024

Add to watchlist:

No watchlists yet
View on USPTO

MIRA Trademark

Serial Number: 98882583 • Registration: 8074067

MIRA is a trademark filed by Quanovate Tech Inc. on December 3, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Quanovate Tech Inc. (7 trademarks)

Pleasanton, CA 94588

Entity Type: 03

Trademark Details

Filing Date

December 3, 2024

Registration Date

December 23, 2025

First Use Anywhere

December 13, 2018

First Use in Commerce

December 13, 2018

Published for Opposition

November 4, 2025

Goods & Services

Diagnostic apparatus for medical use in connection with reproductive medicine, namely, for recognizing physiological and other changes during fertility stages including perimenopause and menopause; Test kits comprising hormone monitor and also including medical diagnostic reagents and assays for detecting, measuring, and monitoring hormones and other markers associated with women's health including fertility and menopause

Downloadable software, for use with medical patient monitoring equipment for data storage and data sharing between health providers and product users; Downloadable software for recording, tracking and predicting stages of fertility including perimenopause and menopause; Downloadable medical and telemedicine software applications for data storage and data sharing between health providers and product users; downloadable mobile application for monitoring the stages of fertility including perimenopause and menopause

Test kits comprising medical diagnostic reagents and assays, urine test wands and also including hormone monitor for detecting, measuring, and monitoring hormones and other markers associated with women's health including fertility and menopause; Medical diagnostic kits comprising medical diagnostic reagents and assays, urine test wands and also including hormone monitor for detecting and evaluating hormone levels related to menopause, perimenopause, fertility, pregnancy, and ovulation; medical test kits comprising medical diagnostic reagents and assays, urine test wands and also including hormone monitor for hormone monitoring; Fertility products, namely hormone and ovulation test kits comprising medical diagnostic reagents and assays, urine test wands and also including hormone monitor; Women's health products, namely hormone and ovulation testing kits; Medical diagnostic test strips for detecting and monitoring hormone levels related to fertility, ovulation, pregnancy, perimenopause, and menopause; At-home women's health tests comprising medical diagnostic reagents and assays, urine test wands and also including hormone monitor to detect and monitor female hormones; At-home fertility test kits comprising medical diagnostic reagents and assays, urine test wands and also including hormone monitor to detect and monitor hormones related to fertility including perimenopause, and menopause

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 23, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 23, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 4, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 4, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 29, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 3, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 28, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 27, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 27, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 27, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 27, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 27, 2025 CNRT
ASSIGNED TO EXAMINER
May 22, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2025 NWOS
NEW APPLICATION ENTERED
Dec 3, 2024 NWAP